NCT04192526

Brief Summary

Metal phosphides are widely used as a rodenticide and insecticide and poisoning with these substances has a very high mortality. The aim of this study was to evaluate the butyrylcholinesterase (BuCh) level in poisoning with metal phosphides.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 6, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 10, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2020

Completed
Last Updated

May 13, 2020

Status Verified

May 1, 2020

Enrollment Period

5 months

First QC Date

December 6, 2019

Last Update Submit

May 11, 2020

Conditions

Toxicity;Chemical

Keywords

serum cholinestrase, atropin, aluminum phosphide

Outcome Measures

Primary Outcomes (1)

  • persistent cholineastrase inhibition is one of the pathological pathway of the ALP poisoning

    definite assessment of the pathogenesis of ALP helps in applying adaquqte treatment regmin

    3 months

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

cases of aluminum phosphide poisoning attending Assiut University Hospitals

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AssiutU

Asyut, Egypt

Location

Study Officials

  • Doaa Abd el rahman

    AssiutU, faculty of medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecture

Study Record Dates

First Submitted

December 6, 2019

First Posted

December 10, 2019

Study Start

December 1, 2019

Primary Completion

April 30, 2020

Study Completion

July 30, 2020

Last Updated

May 13, 2020

Record last verified: 2020-05

Locations

EG(1)